Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 86 results found. Search for [ Pfizer vaccine candidate ]

Results 1 to 21 of 86
BusinessToday.In
October 20, 2020
Speaking during The Wall Street Journal's annual Tech Live conference on October 19, Moderna CEO Stephane Bancel said if satisfactory interim results from the study take longer to get, government authorisation of the COVID-19 vaccine may not happen until early next year


PTI
October 20, 2020
Israel had claimed in August that it already has the vaccine against the coronavirus \"in hand\" but it has to go through regulatory processes that would begin with human trials following the autumn holidays


BusinessToday.In
October 19, 2020
Presently, there are around 40 different coronavirus vaccines in various stages of human clinical trials, comprising one being developed by Oxford University and AstraZeneca, which is already in an advanced stage of testing


BusinessToday.In
October 16, 2020
Pfizer and BioNTech's vaccine candidate, BNT162b2, is currently being evaluated in a global Phase 3 study ongoing at more than 120 clinical sites worldwide including the United States, Brazil, South Africa and Argentina


BusinessToday.In
October 13, 2020
Johnson & Johnson sent out a document in which it stated the \"pausing rule\" has been met and the online system used to enrol patients in the study has been closed


BusinessToday.In
October 12, 2020
Coronavirus vaccine: There are four US-based companies whose vaccine candidates have moved into the crucial phase-3 development phase. This includes--Pfizer, Moderna, Johnson & Johnson, and Novavax


BusinessToday.In
October 1, 2020
Coronavirus vaccine update: In India, there are three COVID-19 vaccines under human trials--Bharat Biotech's COVAXIN, Oxford's COVDSHIELD, and Zydus Cadila's ZyCoV-D. Serum Institute has already begun a phase-3 trial of Oxford vaccine candidates at 17 sites


BusinessToday.In
September 30, 2020
COVID-19 vaccine being developed by AstraZeneca-Oxford University, Novavax, Moderna, Pfizer Inc and Johnson & Johnson are already in an advanced stage of testing


BusinessToday.In
September 23, 2020
Pharma giant Johnson & Johnson (J&J) has started a massive global phase 3 clinical trial with 60,000 people of its single-dose coronavirus vaccine


Reuters
September 22, 2020
Vaccines must be authorised by EMA before they can be used in the European Union. No COVID-19 vaccine has been authorised in Europe


BusinessToday.In
September 22, 2020
Gagandeep Kang, professor of microbiology at Christian Medical College said that by year-end, data on which vaccine candidate is working and which not will be made available


Reuters
September 18, 2020
In recent weeks, Pfizer has said it should know by the end of October whether the vaccine, developed together with Germany's BioNTech SE, is safe and effective


BusinessToday.In
September 16, 2020
Coronavirus vaccine trials: While China has four vaccine candidates in third or final stages of clinical trials, there are at least two companies from the United States and one from UK and Germany, which are planning to rollout vaccine before December, if everything goes as per the plan


Reuters
September 16, 2020
In August, Novavax signed a deal with Serum Institute, the world's largest producer of vaccines, to produce a minimum of one billion doses of its vaccine candidate, when approved, for low- and middle-income countries and India


BusinessToday.In
September 14, 2020
The DCGI had issued a show-cause notice to Serum Institute of India on September 9 for not informing it about AstraZeneca pausing clinical trials of the vaccine candidate in other countries


BusinessToday.In
September 13, 2020
Pfizer says trial is event-based and there are many variables that will ultimately impact read-out timing; adds if trials are successful, these companies would submit vaccines for approval as early as October


BusinessToday.In
September 9, 2020
AstraZeneca said in a statement that its COVID-19 vaccine candidate's trials have been halted, not stopped, as it is going to conduct a review of safety data by an independent committee


Associated Press
September 9, 2020
Late last month, AstraZeneca began recruiting 30,000 people in the US for its largest study of the vaccine. It also is testing the vaccine, developed by Oxford University, in thousands of people in Britain


Reuters
September 8, 2020
Germany's vaccines regulator, the Paul Ehrlich Institute, gave the approval for the Phase 2/3 trial of the experimental vaccine known as BNT162b2, BioNTech and its partner Pfizer said in a statement


Reuters
September 4, 2020
\"We are really not expecting to see widespread vaccination until the middle of next year,\" WHO spokeswoman Margaret Harris told


PAGES 1 OF 5  12345